Matches in Nanopublications for { ?s ?p "[To test whether the HES1-derived NSCs can be used for cancer gene therapy, we used a baculoviral vector to introduce the herpes simplex virus thymidine kinase suicide gene into the cells and demonstrated that baculovirus-mediated transgene expression may last for at least 3 weeks in NSCs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- NP465763.RAZPd4wPQfnaiks3_YsnP-rWb48JVrcn77cop0Y_aYQto130_assertion description "[To test whether the HES1-derived NSCs can be used for cancer gene therapy, we used a baculoviral vector to introduce the herpes simplex virus thymidine kinase suicide gene into the cells and demonstrated that baculovirus-mediated transgene expression may last for at least 3 weeks in NSCs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP465763.RAZPd4wPQfnaiks3_YsnP-rWb48JVrcn77cop0Y_aYQto130_provenance.
- NP793037.RAZUZVwy0qIereN2SON5DjqAVHGFwa_vgVd5OjSTZvhH4130_assertion description "[To test whether the HES1-derived NSCs can be used for cancer gene therapy, we used a baculoviral vector to introduce the herpes simplex virus thymidine kinase suicide gene into the cells and demonstrated that baculovirus-mediated transgene expression may last for at least 3 weeks in NSCs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP793037.RAZUZVwy0qIereN2SON5DjqAVHGFwa_vgVd5OjSTZvhH4130_provenance.
- NP793130.RAWMIrmCaWQIJM8ksq6-8FDVp--dG30IKLukuMEluHI3Y130_assertion description "[To test whether the HES1-derived NSCs can be used for cancer gene therapy, we used a baculoviral vector to introduce the herpes simplex virus thymidine kinase suicide gene into the cells and demonstrated that baculovirus-mediated transgene expression may last for at least 3 weeks in NSCs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP793130.RAWMIrmCaWQIJM8ksq6-8FDVp--dG30IKLukuMEluHI3Y130_provenance.
- assertion description "[To test whether the HES1-derived NSCs can be used for cancer gene therapy, we used a baculoviral vector to introduce the herpes simplex virus thymidine kinase suicide gene into the cells and demonstrated that baculovirus-mediated transgene expression may last for at least 3 weeks in NSCs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP465668.RAuD7jbkr8sTr4yMOzxUP6ZMTIZv_YYoprB58lB76BV4c130_assertion description "[To test whether the HES1-derived NSCs can be used for cancer gene therapy, we used a baculoviral vector to introduce the herpes simplex virus thymidine kinase suicide gene into the cells and demonstrated that baculovirus-mediated transgene expression may last for at least 3 weeks in NSCs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP465668.RAuD7jbkr8sTr4yMOzxUP6ZMTIZv_YYoprB58lB76BV4c130_provenance.
- NP1018083.RAh-l-Rhwtr5onkTjEq59juPnlcVtmIPnpTF6Q9Sl9DBQ130_assertion description "[To test whether the HES1-derived NSCs can be used for cancer gene therapy, we used a baculoviral vector to introduce the herpes simplex virus thymidine kinase suicide gene into the cells and demonstrated that baculovirus-mediated transgene expression may last for at least 3 weeks in NSCs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1018083.RAh-l-Rhwtr5onkTjEq59juPnlcVtmIPnpTF6Q9Sl9DBQ130_provenance.
- NP1018176.RAJh7AkLPytWvnHR4Jc5ImesUFagDKAhaiUA9CuVORne4130_assertion description "[To test whether the HES1-derived NSCs can be used for cancer gene therapy, we used a baculoviral vector to introduce the herpes simplex virus thymidine kinase suicide gene into the cells and demonstrated that baculovirus-mediated transgene expression may last for at least 3 weeks in NSCs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1018176.RAJh7AkLPytWvnHR4Jc5ImesUFagDKAhaiUA9CuVORne4130_provenance.